Bruce Montgomery

Former CEO, Avalyn Pharma Inc.

Role: Associate

Site: CDL-Seattle

Stream: Computational Health

Bruce Montgomery is both a physician scientist and an entrepreneur that has been a leader in bringing new discoveries related to pulmonary and critical care medicine to the bedside. He has led development teams for new medical therapies for patients with cystic fibrosis, including Cayston, TOBI, and Pulmozyme. All improve respiratory symptoms in cystic fibrosis patients. In the 1980s, he co-invented aerosolized pentamidine, a prophylaxis for PCP, then the most common cause of death in patients with AIDS. He is an inventor with 28 US patents. He has been the CEO or the research head of three Seattle-based biotech companies. Bruce received his bachelor’s in chemistry and M.D. degrees from the University of Washington and is a board-certified internist and pulmonologist. In 2012, he was recognized by the University of Washington as a recipient of a timeless award honouring the top 150 living graduates of the college of arts and sciences as a celebration of the school’s sesquicentennial.